ID
12647
Description
Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT); ODM derived from: https://clinicaltrials.gov/show/NCT01339988
Link
https://clinicaltrials.gov/show/NCT01339988
Keywords
Versions (1)
- 12/7/15 12/7/15 -
Uploaded on
December 7, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Leukemias NCT01339988
Eligibility Acute Leukemias NCT01339988
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
patients with neoplastic or non-neoplastic disease of any major organ system that would compromise their ability to withstand the pre-transplant conditioning regimen
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
patients with uncontrolled (culture or biopsy positive) infections requiring intravenous antivirals, antibiotics, or antifungals
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
patients who are pregnant or lactating. patients of childbearing potential must practice an effective method of birth control while participating on this treatment plan.
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C2828358
- UMLS CUI [3]
- C0700589
Description
hiv seropositive patients
Data type
boolean
Alias
- UMLS CUI [1]
- C0019699
Similar models
Eligibility Acute Leukemias NCT01339988
- StudyEvent: Eligibility
C0032181 (UMLS CUI [2])
C0201913 (UMLS CUI [2])
C2828358 (UMLS CUI [2])
C0700589 (UMLS CUI [3])